-
β-PGG Targets PCID2 in Hepatocellular Carcinoma
2026-08-12
A 2025 Frontiers in Pharmacology study combined structure-based virtual screening with surface plasmon resonance and cellular assays to identify β-PGG as a natural compound that directly binds PCID2. The findings connect PCID2 modulation with reduced hepatocellular carcinoma proliferation, migration, and invasion, alongside apoptosis, cell-cycle disruption, and changes in PI3K/Akt signaling.
-
Ac-YVAD-CMK for Caspase-1 Inflammation Studies
2026-08-12
Ac-YVAD-CMK helps separate caspase-1-dependent cytokine maturation from upstream membrane injury in infection and pyroptosis models. This workflow translates Kupffer cell and TMEM16F findings into practical controls for measuring IL-1β, IL-18, cell lysis, and inflammatory pathway selectivity.
-
Panobinostat Induces Calcineurin Degradation in Myeloma
2026-08-11
The reference study identifies degradation of the calcineurin catalytic subunit PPP3CA as a previously underappreciated mechanism of panobinostat activity in multiple myeloma. Its findings connect PPP3CA abundance with advanced disease and bortezomib resistance, while supporting combined HDAC and calcineurin inhibition as a preclinical strategy.
-
BHQ: Turning SERCA Biology into Translation
2026-08-11
A mechanistic and strategic guide to using 2,5-di-tert-butylbenzene-1,4-diol (BHQ) to interrogate calcium homeostasis, ER stress, vascular physiology, and hematopoietic stem cell mobilization.
-
Ac-YVAD-CMK: Reading Liver Inflammation
2026-08-10
A translational framework for using Ac-YVAD-CMK to test whether caspase-1-dependent cytokine maturation and pyroptotic signaling contribute to Kupffer cell injury during Listeria infection, while separating membrane damage from inflammatory amplification.
-
ORAI2-Driven SOCE in Salivary Gland Fibrosis
2026-08-09
The reference study identifies ORAI2-mediated store-operated calcium entry as an important driver of early postirradiation salivary gland fibrosis and defines an ORAI2/JNK/NFAT1/TGF-β1 signaling axis. Its combination of transcriptomics, pharmacologic pathway inhibition, and saliva-flow assessment provides a mechanistic framework for studying radiation-induced hyposalivation.
-
Cell Counting Kit-8 Plus in Cancer Assays
2026-08-08
Cell Counting Kit-8 Plus enables rapid, sensitive viability measurement, but its interpretation depends on cellular metabolism. This article explains how to use a WST-8 tetrazolium salt assay intelligently in lactate-rich clear cell renal cell carcinoma and autophagy research.
-
Griseofulvin: A Mechanism-First Assay Guide
2026-08-07
Griseofulvin is a microtubule associated inhibitor that connects fungal cell mitosis inhibition with rigorous pathway-level assay design. This guide explains how to use its mechanistic profile, formulation data, and aneugenicity assay principles to build more interpretable antifungal drug research workflows.
-
Docetaxel as a Quantitative Benchmark in Cancer Drug Respons
2026-08-07
Discover how Docetaxel enables deeper, quantitative insight into cancer chemotherapy research. This article explores Docetaxel's unique role in refining in vitro assay design and interpretation, offering advanced guidance for oncology investigators.
-
Bclaf1 Modulates c-FLIP to Protect Against TNF-Induced Apopt
2026-08-06
This study identifies Bclaf1 as a critical regulator of c-FLIP expression, demonstrating its essential role in protecting cells from TNF-induced apoptosis and tissue injury. By elucidating how Bclaf1 interacts with the NF-κB pathway to promote anti-apoptotic signaling, the findings provide mechanistic insight with direct implications for apoptosis assays and translational research.
-
GPX4-Driven GSH Consumption Mediates Chemoresistance in Lung
2026-08-06
This study uncovers how glutathione peroxidase 4 (GPX4)-dependent glutathione (GSH) consumption confers platinum chemoresistance in lung cancer-derived brain metastases. By integrating metabolomics, proteomics, and functional assays, the researchers demonstrate that high GSH turnover and GPX4 upregulation suppress ferroptosis, suggesting novel strategies to overcome resistance in metastatic lung cancer.
-
Y-27632: Selective ROCK Inhibitor for Cytoskeletal Modulatio
2026-08-05
Y-27632 is a highly selective ROCK inhibitor used to dissect cytoskeletal dynamics in cell biology and stem cell research. Its ATP-competitive, reversible inhibition profile enables precise modulation of actin stress fibers, facilitating advanced studies in cytoskeleton and disease modeling.
-
Nigericin: Potassium/Hydrogen Ion Carrier in Advanced Resear
2026-08-05
Nigericin’s role as a potassium/hydrogen ion carrier enables precise intracellular pH modulation, unlocking new experimental strategies in oncology and antimicrobial resistance. This article provides actionable workflows, optimization tips, and practical troubleshooting, leveraging APExBIO’s high-purity Nigericin for reproducible, cutting-edge research.
-
Maternal IL-17A as a Prognostic Biomarker in GBS Colonizatio
2026-08-04
A recent prospective study establishes maternal IL-17A as a predictive biomarker for neonatal risk in pregnancies colonized with Group B Streptococcus (GBS). Through comprehensive cytokine profiling and ex vivo TLR1/2 pathway stimulation, the research identifies mechanistic links between maternal immune status and vertical GBS transmission, providing a foundation for targeted neonatal risk assessment.
-
USP7 Regulates Macrophage Polarization via PKM2 in Pancreati
2026-08-04
This study elucidates how ubiquitin-specific protease 7 (USP7) drives inflammatory macrophage polarization in severe acute pancreatitis (SAP) by modulating the metabolic enzyme pyruvate kinase M2 (PKM2). The findings provide mechanistic insight into immunometabolic regulation and suggest PKM2 as a promising target for inflammatory disease intervention.